Immuneering Corp (IMRX)
NGM · Common · CUSIP 45254E107
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for IMRX and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
45254E107
Market Cap
Mid Cap
IPO
7/30/2021 · $15.00/share
Business: Immuneering Corp is a biopharmaceutical company with an emerging pipeline focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying its deep knowledge of translational bioinformatics to every stage of the drug development process.

Company Contact

CEO
Benjamin J. Zeskind
CFO
Mallory Morales
Headquarters
245 Main Street, Second Floor, Cambridge, MA 02142
Phone
617-500-8080
Investor Relations
Rebecca Kusko · 617-500-8080 · rkusko@immuneering.com
SEC EDGAR Filings
View filings »